Kiniksa Pharmaceuticals International, plc Current Assets
Kiniksa Pharmaceuticals International, plc (KNSA) had Current Assets of $594.17 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-04-28
- 2026-03-31: Assets, Current $594.17M.
- 2025-12-31: Assets, Current $527.18M.
- 2025-09-30: Assets, Current $475.53M.
- 2025-06-30: Assets, Current $420.31M.
| Period end | Assets, Current |
|---|---|
| 2026-03-31 | $594.17M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $527.18M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $475.53M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $420.31M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $355.91M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $331.80M 10-K · filed 2026-02-24 |
| 2024-09-30 | $311.30M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $301.02M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $270.59M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $276.30M 10-K · filed 2025-02-25 |
| 2023-09-30 | $256.11M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $246.04M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $231.50M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $243.06M 10-K · filed 2024-02-28 |
| 2022-09-30 | $241.81M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $179.94M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $198.76M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $196.45M 10-K · filed 2023-03-02 |
| 2021-09-30 | $217.51M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $244.81M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $275.56M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $333.25M 10-K · filed 2022-02-24 |
| 2020-09-30 | $378.41M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $264.49M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $213.06M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $241.63M 10-K · filed 2021-02-25 |
| 2019-09-30 | $268.34M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $296.46M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $334.96M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $313.75M 10-K · filed 2020-03-05 |
| 2018-09-30 | $341.53M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $363.87M 10-Q · filed 2018-08-06 |
| 2017-12-31 | $47.10M 10-K · filed 2019-03-12 |